Patents by Inventor Barbara Di Ventura

Barbara Di Ventura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NON-RIBOSOMAL PROTEIN SYNTHESIS PIGMENT FUSION PEPTIDES
    Publication number: 20160238611
    Abstract: The present invention relates to a polypeptide or polypeptide complex, comprising at least one non-ribosomal peptide synthesis (NRPS) amino acid module functionally connected to at least one pigment module. The present invention further relates to a labeled oligopeptide comprising a non-naturally attached NRPS pigment or/and polyketide pigment, to a polynucleotide encoding a fusion polypeptide, a vector, preferably an expression vector, comprising the polynucleotide of the present invention and to a host cell comprising the polypeptide or polypeptide complex and/or the polynucleotide, and/or the vector according to the present invention. Moreover, the present invention relates to in vitro and in vivo method of producing a labeled oligopeptide, as well as to methods of optimizing the same.
    Type: Application
    Filed: October 2, 2014
    Publication date: August 18, 2016
    Inventors: Roland EILS, Barbara DI VENTURA, Lorenz ADLUNG, Katharina GENREITH, Tim HEINEMANN, Hannah MEYER, Dominik NIOPEK, Fanny GEORGI, Ralf BEER, Tania Christina CHRISTIANSEN, Konrad HERBST, Nikolaos IGNATIADIS, Ilia KATS, Nils KURZAWA, Johanna MEICHSNER, Sophie RABE, Anja RIEDEL, Joshua SACHS, Julia Patricia SCHESSNER, Florian SCHMIDT, Philipp Darius Konstantin WALCH
  • USE OF BACTERIA FOR THE SENSING AND KILLING OF CANCER CELLS
    Publication number: 20110293567
    Abstract: The present invention relates to the field of cancer therapy. Specifically, a chemotaxis fusion-receptor that directs bacteria towards tumors is disclosed. Further encompassed by the present invention is a bacterial cell that comprises at least one chemotaxis fusion-receptor and, preferably, a killing module for the destruction of tumor cells.
    Type: Application
    Filed: October 26, 2009
    Publication date: December 1, 2011
    Applicants: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG, DKFZ DEUTCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS
    Inventors: Roland Eils, Philip Hundeshagen, Yara Reis, Daniela Richter, Jens Keienburg, Michaela Reichenzeller, Michael Flossdorf, David Kentner, Erik Sommer, Victor Sourjik, Barbara Di Ventura, Philip Bayer, Yin Cai, Maximilian Hörner, Stephen Kraemer, Pascal Krämer, Andreas Kühne, Christian Moritz, Maria Renner, Dominik Niopek, Kathrin Nussbaum, Kolja Schleich, Markus Stahlberg, Anna Stöckl, Chenchen Zhu, Marika Ziesack, Adjana Eils, Nikita Vladimirov